| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |